Coumarin-amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition.
Autor: | El-Etrawy AS; Department of Chemistry, Basic Science Center, Misr University for Science and Technology (MUST) Al-Motamayez District 6th of the October City 77 Egypt.; Department of Pharmaceutical Organic Chemistry College of Pharmaceutical Science & Drug Manufacturing, Misr University for Science and Technology (MUST) Al-Motamayez District 6th of the October City 77 Egypt., Ramadan A; Department of Chemistry, Faculty of Science, Menoufia University Shebin El-Koam Egypt., Sherbiny FF; Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy (Boys), Al-Azhar University Cairo 11884 Egypt dr-farag-sherbiny@azhar.edu.eg., Zeid IF; Department of Chemistry, Faculty of Science, Menoufia University Shebin El-Koam Egypt., Abdel-Rahman AA; Department of Chemistry, Faculty of Science, Menoufia University Shebin El-Koam Egypt., Hawata MA; Department of Chemistry, Faculty of Science, Menoufia University Shebin El-Koam Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | RSC advances [RSC Adv] 2024 Aug 06; Vol. 14 (34), pp. 24671-24686. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024). |
DOI: | 10.1039/d4ra04226c |
Abstrakt: | A series of mono-peptide, di-peptide and tri-peptide derivatives linked to a coumarin scaffold (5a-c, 7a-c, and 9a-c) were synthesized via the azide-coupling method from corresponding hydrazides 4, 6, and 8. These compounds were tested for anticancer activity against HepG-2, PC-3, and Hct-116 cell lines. Compounds, 7c, and 5b showed significant cytotoxicity, outperforming doxorubicin, with IC Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (This journal is © The Royal Society of Chemistry.) |
Databáze: | MEDLINE |
Externí odkaz: |